AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Redcare Pharmacy N.V.

Report Publication Announcement Feb 2, 2024

6219_rns_2024-02-02_e4560638-a715-4739-931b-9d73c8c3bab6.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

News Details

Advance Financial Reports | 2 February 2024 19:35

Redcare Pharmacy N.V.: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

Redcare Pharmacy N.V. / Preliminary announcement on the disclosure of financial statements

Redcare Pharmacy N.V.: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

02.02.2024 / 19:35 CET/CEST

Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

Redcare Pharmacy N.V. hereby announces that the following financial reports shall be disclosed:

Report Type: Annual financial report of the group

Language: English

Date of disclosure: March 05, 2024

Address: https://ir.redcare-pharmacy.com/publikationen

Report Type: Financial report of the group (half-year/Q2)

Language: English

Date of disclosure: July 30, 2024

Address: https://ir.redcare-pharmacy.com/publikationen


02.02.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com


Language: English
Company: Redcare Pharmacy N.V.
Erik de Rodeweg 11-13
5975 WD Sevenum
Netherlands
Internet: www.redcare-pharmacy.com
End of News EQS News Service

show this

Talk to a Data Expert

Have a question? We'll get back to you promptly.